Liq­uidia sues FDA over ex­clu­siv­i­ty de­ci­sion to de­lay Yutrepi­a's full ap­proval

Liq­uidia has filed a law­suit against the FDA over its de­ci­sion to grant three years of ex­clu­siv­i­ty to Unit­ed Ther­a­peu­tics’ drug Ty­va­so, which com­petes against …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER